Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain 2024-05-08 20:00
Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting 2024-05-08 18:18
Andall Biosciences Introduces 23WELL: A Breakthrough New Brand with Ovary Care Capsules (1+1) as its Stellar Debut Product 2024-05-08 18:11
FDA Grants Orphan Drug Designation to 9MW2821 2024-05-07 22:00
Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024 2024-05-07 21:08
GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024 2024-05-07 13:27
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease 2024-05-03 19:00
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers 2024-05-02 07:01
Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry 2024-05-01 17:14
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - A Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific Presentations 2024-04-30 23:00
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma 2024-04-30 20:55
A Potential First-In-Class Drug: CDE Approved Single-Arm Pivotal Clinical Study of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs 2024-04-30 20:16
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update 2024-04-30 19:00
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment 2024-04-30 10:55
CARsgen Submitted Responses to FDA Observations 2024-04-29 20:50
Technoderma Medicines Advances TDM-180935 Atopic Dermatitis Clinical Program with Phase 2 Trial 2024-04-29 20:00
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations 2024-04-29 19:00
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative 2024-04-29 15:31
Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC 2024-04-26 21:00
1 18 19 20 21 22 222